Introduction:
The ICICI Group, officially known as the Industrial Credit and Investment Corporation of India, is among India’s largest financial services conglomerates. Established in 1955, it has significantly contributed to economic development through a wide array of banking and financial solutions.
The group holds investments in 259 publicly traded stocks with a combined net worth exceeding Rs. 494,399.1 crores, highlighting its diversified portfolio. These investments reflect the group’s strategic focus on sectors crucial to India’s economic growth, backed by its financial expertise.
Recently, ICICI Group acquired fresh stakes in three prominent stocks. This move aligns with its strategy of capitalizing on emerging opportunities across various sectors, reinforcing its position as a key player in India’s financial and investment landscape.
Also Read: EV stocks jump more than 5% after Govt restores subsidies for electric three-wheelers
Ambuja Cements Ltd
On November 19, Ambuja Cements Ltd opened at ₹550.05 and reached an intraday high of ₹560.00 before closing at ₹552.00, up by 0.31% from the previous close of ₹550.30. Of that day, the market cap was ₹1,35,964.42 crore.
By 10:00 AM, the stock was trading at ₹551.75, representing a 0.31% increase.
Ambuja Cements Ltd (NSE: AMBUJACEM), one of India’s leading cement manufacturers, specializes in sustainable and innovative building solutions. Established in 1983, it is a subsidiary of the Holcim Group. The company is renowned for its high-quality cement products and strong focus on environmental conservation through cutting-edge technologies and practices.
Amrutanjan Health Care Ltd
On November 19, 2024, Amrutanjan Health Care Ltd. opened at ₹708.95, marking a 0.77% increase from its previous close of ₹703.50. The stock reached an intraday high of ₹769.95, up 9.44%, and an intraday low of ₹705.60.
By 16:00, it was trading at ₹720.90, reflecting a 2.47% increase. The market capitalization for the day stood at ₹2,107.24 crore.
Amrutanjan Health Care Ltd (NSE: AMRUTANJAN), founded in 1893, is a trusted name in pain relief and healthcare products. Known for its iconic balm, the company offers a range of ayurvedic and allopathic solutions. It emphasizes innovation, quality, and wellness, catering to diverse consumer needs across India and global markets.
Also Read: Gujarat Themis Biosyn Merger: How many shares will you receive for every share of Themis Biosyn?
Graphite India Ltd
On November 19, 2024, Graphite India Ltd. opened at ₹480.00, marking a 0.78% increase from its previous close of ₹476.25. The stock reached an intraday high of ₹486.00, up 2.05%, and an intraday low of ₹471.55.
By 16:00, it was trading at ₹474.95, reflecting a 0.27% decrease. The market capitalization for the day stood at ₹9,279.36 crore.
Graphite India Ltd (NSE: GRAPHITE) is a leading manufacturer of graphite electrodes and carbon products in India. Established in 1967, the company serves the steel and other industries worldwide. With advanced production capabilities and global presence, it focuses on innovation and sustainable practices to meet dynamic industry demands.
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time The securities quoted are exemplary and are not recommendatory.
